Most recently and in agreement with our present results, it has been reported that the reduction of miR-214 expression in breast cancer cells associated with increase in cell proliferation, invasion, and accumulation of the polycomb EZH2 methyltransferase [32] and that EZH2 protein expression can be a sensitivity diagnostic biomarker for HCC [40]. This evidence concerns the gene EZH2 and breast carcinoma.